Neonatal cytokines and cerebral palsy in very preterm infants

Pediatr Res. 2003 Apr;53(4):600-7. doi: 10.1203/01.PDR.0000056802.22454.AB. Epub 2003 Feb 5.

Abstract

To examine the relationship of cytokines in blood of very preterm neonates with later diagnosis of spastic cerebral palsy (CP) compared with infants of similar gestational age without CP, we measured concentrations of inflammatory cytokines and other substances in archived neonatal blood by recycling immunoaffinity chromatography. Subjects were surviving children born before 32 wk gestational age (GA) to women without preeclampsia, 64 with later diagnoses of CP and 107 control children. The initial analyses were augmented by measurement of 11 cytokines by a bead-based flow analytic system (Luminex) in an additional 37 children with CP and 34 control children from the same cohort. Concentrations of examined substances did not differ by presence of indicators of infection in mother, infant, or placenta. On ANOVA, concentrations of a number of cytokines were significantly related to neonatal ultrasound abnormalities (periventricular leukomalacia, ventricular enlargement, or moderate or severe germinal matrix hemorrhage). None of the substances measured either by immunoaffinity chromatography or flow analytic methods, including IL-1, -6, and -8 and tumor necrosis factor-alpha, was related to later diagnosis of CP or its subtypes. Inflammatory cytokines in neonatal blood of very premature infants did not distinguish those with later diagnoses of CP from control children.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers
  • Birth Weight
  • Cerebral Palsy / blood*
  • Cerebral Palsy / diagnostic imaging
  • Cerebral Palsy / immunology*
  • Chromatography, Affinity
  • Cohort Studies
  • Cytokines / blood*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature / immunology*
  • Predictive Value of Tests
  • Skull / diagnostic imaging
  • Ultrasonography

Substances

  • Biomarkers
  • Cytokines